Decheng Capital as of March 31, 2025
Portfolio Holdings for Decheng Capital
Decheng Capital holds 27 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 43.8 | $156M | 6.4M | 24.49 | |
| Nuvation Bio (NUVB) | 12.8 | $46M | 26M | 1.76 | |
| Aardvark Therapeutics (AARD) | 8.3 | $29M | 3.9M | 7.51 | |
| Upstream Bio (UPB) | 5.6 | $20M | 3.3M | 6.12 | |
| Newamsterdam Pharma Co Nv (NAMS) | 4.4 | $16M | 770k | 20.47 | |
| Krystal Biotech (KRYS) | 3.3 | $12M | 65k | 180.30 | |
| Revolution Medicines (RVMD) | 2.2 | $8.0M | 226k | 35.36 | |
| Merus N V (MRUS) | 2.2 | $8.0M | 189k | 42.09 | |
| BeyondSpring SHS (BYSI) | 2.0 | $7.0M | 4.9M | 1.43 | |
| Helix Acquisition Corp | 1.9 | $6.7M | 172k | 39.07 | |
| Lyell Immunopharma | 1.8 | $6.4M | 12M | 0.54 | |
| Arcus Biosciences Incorporated (RCUS) | 1.8 | $6.3M | 809k | 7.85 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $6.2M | 4.0M | 1.53 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $6.0M | 178k | 33.54 | |
| Cytokinetics (CYTK) | 1.1 | $4.0M | 100k | 40.19 | |
| Legend Biotech Corp- Adr (LEGN) | 1.0 | $3.4M | 100k | 33.93 | |
| Arcellx (ACLX) | 0.9 | $3.3M | 50k | 65.60 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.9 | $3.2M | 2.0M | 1.59 | |
| Aura Biosciences (AURA) | 0.8 | $3.0M | 516k | 5.86 | |
| Biontech Se (BNTX) | 0.5 | $1.8M | 20k | 91.06 | |
| Equillium (EQ) | 0.5 | $1.7M | 4.4M | 0.39 | |
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $1.1M | 336k | 3.23 | |
| Illumina (ILMN) | 0.3 | $932k | 12k | 79.34 | |
| Pyxis Oncology (PYXS) | 0.1 | $320k | 327k | 0.98 | |
| Grail (GRAL) | 0.1 | $247k | 9.7k | 25.54 | |
| Vera Therapeutics (VERA) | 0.0 | $108k | 4.5k | 24.02 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $44k | 646k | 0.07 |
